Amicus therapeutics inc

Major-Pharmaceuticals

FOLD


1 Cedar Brook Drive
Cranbury , NJ 08512

Executive/
Director

Price

  • Last Close
  • $ 11.3
    $ +0.09 0.8 %
    Aug 29, 2024
  • 52-Week High/Low
  • $14.52 - $9.37
  • YTD
  • -20.4%

  • Trading Volume
  • 144,485
  • Market Cap Full
  • $ 3.3B
  • Shares Outstanding
  • 293.2M
    Oct 25, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 30.8% -12.9% 43.5% 4.5% 42% -5% -57.3% -18% -9.2% -17%
Q2 30.1% -35.4% 41.2% 10.3% -8.8% 4% -2.4% 13.4% 13.3% -3.2%
Q3 -1.1% 35.5% 49.8% -21.9% -35.8% 8% -0.9% -2.8% -3.2% -
Q4 -30.7% -32.8% -4% -25.2% 22.4% 64% 20.9% 17% 28.7% -
J F M A M J J A S O N D
2024 -12.4% 3.1% -8.1% -3.5% - - - - - - - -
2023 6.8% 1.2% -15.9% 4.1% -2.4% 11.6% 8.4% -5.9% -5.2% -9.8% 0.5% 28.8%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    254%17%-49%190%-33%2%137%-50%6%16%-20%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.25 0.35 0.39 -0.28 -0.56 -0.35 -0.25 -0.3 -0.18
Q2 0.26 0.40 0.34 -0.33 -0.36 -0.2 -0.19 -0.21 -0.15
Q3 0.32 0.33 0.41 -0.84 -0.24 -0.25 -0.19 -0.12 -0.07
Q4 0.35 0.32 0.41 -0.43 -0.32 -0.27 -0.29 -0.19 -
A 1.2 1.4 1.6 -1.9 -1.5 -1.1 -0.9 -0.8 -0.4

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 223.7 257.2 264.3 280 282.7
Jun 188.5 230.5 257.7 266.1 280.2 284.6
Sep 189.1 254.6 258.8 266.6 280.5 287.1
Dec 189.3 254.8 260.6 278.6 280.9 293.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.6 1.3 1.6 1.6 1.8
Fixed Asset Turnover 4.5 3.4 3 1.8 2.2
Total Asset Turnover 0.5 0.3 0.3 0.2 0.1
Leverage
Debt Ratio 0.9 0.7 0.7 0.3 0.3
Debt – Equity Ratio 3.2 1.3 1.4 0.3 0.4
Interest Coverage -8.5 -4.7 -8.2 -5.9 -16.5
Equity multiplier 0.6 0.3 0.3 0.2 0.1